Organisation | Italian Medicines Agency

Source: https://www.aifa.gov.it/organizzazione1

Archived: 2026-04-23 17:25

Organisation |
Italian Medicines Agency
Aifa toggle bar Search
Search keywords
The Agency
The Agency
Mission and values
Organisation
Scientific and Economic Committee for Medicines
Support and Coordination Secretariats and Advisory Committees
International Collaborations
EU Projects
Legislation
Forms
Competition notices
Resolutions
Tenders and contracts
Quality assurance
Guarantee Committee
Atti di notifica
Associazioni dei pazienti
AIFA Incontra
Contacts
Certified email
COVID-19
COVID-19
Communications about COVID-19
COVID-19 Vaccines
Medicines usable for treatment of COVID-19 disease
Use of monoclonal antibodies for COVID-19
Use of antivirals for COVID-19
Monitoring of medicinal products used during the COVID-19 epidemic
Clinical Trials - COVID-19
Compassionate Use Programs - COVID-19
Access to medicinal products
Access to medicinal products
Early access and off-label use
Authorisation of medicinal products
Medicine shortages
Antibiotic medicinal products
Biological medicinal products
Vaccines
Blood derivatives
Generic medicinal products
Biosimilar medicinal products
Orphan medicinal products
Advanced therapies
Homeopathic medicinal products
Allergens
Medicinali di origine vegetale
Ancillary medicinal substances incorporated in medical devices
Safety of medicinal products
Safety of medicinal products
Pharmacovigilance
National Pharmacovigilance Network
Adverse Reactions to medicinal products
Persons in charge of Pharmacovigilance
European Eudravigilance System
Accesso alle segnalazioni - ADRreports
Regional pharmacovigilance funds
Segnali di sicurezza
Risk management measures
Medicinal products subject to additional monitoring
Quality and Inspections
Quality and Inspections
Quality defects
Inspections and authorisations
Qualified person
Fight of pharmaceutical crime
Research and Clinical trials
Research and Clinical trials
Clinical trials concerning medicinal products
EU Regulation on Clinical trials
National Observatory on Clinical Trials
Registro Studi Osservazionali
Comitati Etici Nazionali (CEN)
Ethics Committees Coordination Centre
Independent clinical research
Mappa dei centri di Sperimentazione Clinica
Pricing and reimbursement
Pricing and reimbursement
Negotiation and reimbursement
Economic evaluations
Monitoring Registers
AIFA Notes
Lists of Class A and Class H medicinal products
Innovative medicinal products
Transparency Lists
Consumption and pharmaceutical expenditure
Consumption and pharmaceutical expenditure
The Medicines Utilization Monitoring Centre (OsMed)
Governance of pharmaceutical expenditure
Monitoring pharmaceutical expenditure
Innovation and planning
Innovation and planning
Innovation and scientific advice
Horizon scanning
Information and communication
Information and communication
FarmaciLine
Medical and scientific information
FAQ
Publications
Communication campaigns
Eventi AIFA
Scientific Seminars
Press releases
Dossier AIFA
Mobile APP AIFA
APP Firstline AIFA - Antibiotici
ABC della Ricerca Clinica
Presentations and speeches
Public consultations and documents
Documents shared with scientific communities
Calendario eventi
Archivio
AIFA data
AIFA data
OsMed Data
Open Data
Companies Section
Companies Section
Requests for authorisation of conferences and meetings
Payment of fees and annual duties
MA Electronic invoicing
Application for reimbursement and pricing
Access information
Notifica concessionari di vendita
Comunicazione prima commercializzazione
Open governance
Open governance
Disposizioni Generali
Organizzazione
Consulenti e collaboratori
Personale
Bandi di Concorso
Performance
Enti controllati
Attività e procedimenti
Provvedimenti
Bandi di gara e contratti
Sovvenzioni, contributi, sussidi, vantaggi economici
Bilanci
Beni immobili e gestione patrimonio
Controlli e rilievi sull'Amministrazione
Servizi Erogati
Pagamenti dell'Amministrazione
Opere pubbliche
Pianificazione e governo del territorio
Informazioni ambientali
Interventi straordinari di emergenza
Altri Contenuti
Organisation
Organisation
The Agency is structured into two general Directorates ensuring administrative and technical-scientific management:
Administrative Directorate;
Technical-Scientific Directorate.
The general Directorates are divided into 6 non-general management Divisions and 43 non-general management Offices.
Presidente
Presidente dell'Agenzia Italiana del Farmaco >
AIFA Bodies
The bodies of the Agency are the President, the Board of Directors, and the Board of Auditors.
The Board of Directors consists of the President and four members, one designated by the Minister of Health, one by the Minister of Economy and Finance, and two by the Permanent Conference for Relations between the State, the Regions and the Autonomous Provinces of Trento and Bolzano. Board of Directors
Robert Giovanni Nisticò
-
President
Francesco Fera
- Board Member
Emanuele Monti
- Board Member
Angelo Gratarola
- Board Member
Vito Montanaro
- Board Member
Collegio dei Revisori dei Conti
The Board of Auditors is constituted in accordance with the provisions of Article 48, paragraph 4, letter c, Legislative Decree no. 269 of 30 September 2003, converted, with amendments, by Law no. 24 November 2003 (
establishing law
)
Massimo Zeppieri
- President
Matteo Petrella
- Member
Angelo Vittorio Sestito
- Member
Direzioni Generali
Direttore amministrativo >
Direttore tecnico-scientifico >
Independent Assessment Body
The Independent assessment body of the Italian Medicines Agency is composed as follows:
Valeria Napoli
-
Chairperson
Ettore Avolio
-
Member
Franco Barosi
-
Member
The Body, which has received the favorable opinion by the Department of Public Administration, is assigned the tasks and functions provided for by Legislative Decree 27 October 2009, no. 150. It carries out the strategic control activities referred to in Article 6, paragraph 1, of Legislative Decree 30 July 1999, no. 286.
2016 AIFA Rules and Procedures
Decree of the Minister of Health of 20 September 2004, no. 245 [0.12 Mb] [PDF] >
2025 AIFA Rules and Procedures [0.67 Mb] [PDF] >
Decree of the Minister of Health of 8 January 2024, no. 3 [1.58 Mb] [PDF] >
Organizzazione AIFA
Articolazione uffici in vigore fino al 31/12/2025 [0.14 Mb] [PDF] >
User participation and satisfaction
Organisation Chart
User participation and satisfaction - Questionnaires and reporting form
Site Map
The Agency
Mission and values
Organisation
Presidente
Direttore amministrativo
Direttore tecnico-scientifico
Presidenza
Direzione amministrativa
Direzione Tecnico-Scientifica
Area per la digitalizzazione, il procurement e il patrimonio
Area per le politiche del personale e del bilancio
Area Autorizzazione Medicinali
Area Vigilanza Post-Marketing
Area Pre-autorizzazione e Ricerca
Area Accesso al Farmaco e HTA
Scientific and Economic Committee for Medicines
Support and Coordination Secretariats and Advisory Committees
International Collaborations
EU Projects
Legislation
Forms
Competition notices
Resolutions
Tenders and contracts
Quality assurance
Guarantee Committee
Atti di notifica
Associazioni dei pazienti
AIFA Incontra
Contacts
Certified email
Share
Nested Applications
Press
From one-size-fits-all treatments to personalised care: the revolution in precision medicine
All press releases
Last tweets
📢 #AIFA comunica il calendario degli incontri nell’ambito delle iniziative dedicate al dialogo e al...
Vai al post →
🔬 AIFA pubblica il dossier “Dalle terapie a taglia unica alle cure su misura: la rivoluzione della ...
Vai al post →
🎙️ “Immagino un futuro in cui ciascuno di noi abbia un vero e proprio passaporto farmacogenetico, m...
Vai al post →
💊 Quasi 4 cittadini su 10 hanno ricevuto almeno una prescrizione di #antibiotici nel 2024, con una ...
Vai al post →
⚠️ Attenzione alle false cure miracolose

Negli ultimi tempi si sta diffondendo un business pericol...
Vai al post →
#AIFA promuove l’ascolto e la trasparenza
Approvati i Regolamenti di “AIFA Ascolta” e “AIFA Incontr...
Vai al post →
Go to Twitter profile
Go to Twitter profile
aifa_ufficiale
Multimedia
Medicina di precisione e appropriatezza prescrittiva
Go to YouTube channel
Nested Applications
Open competitions
Consult the list of insolvency procedures for the recruitment of personnel.
Competitions
Tenders
Go to the section that collects information on purchasing procedures.
All tenders
Legislation
Access to applicable legislation.
All legislation
Open governance
Open Data
Open governance
Web accessibility
Nested Applications
Highlights
21/04/2026 - Medicine Use: 2024 Regional Reports Now Available Online
17/04/2026 - From one-size-fits-all treatments to personalised care: the revolution in precision medicine
TUTTE LE NEWS - IN EVIDENZA
ALL NEWS
News
13/04/2026
Medicine Shortage Communication on Endoxan (ciclofosfamide)
13/04/2026
Medicine Shortage Communication on Holoxan (ifosfamide)
27/03/2026
Biosimilars: AIFA webinar on the Third Position Paper
All news
Nested Applications
L'Agenda
08 February
14:00 - 19:00
Riunione Commissione Tecnico Scientifica (CTS)
10 February
15:00
Riunione CDA
18 May
Da definire
Riunione della Commissione Scientifica e Economica del Farmaco (CSE)
ALL EVENTS
Reference offices
Office of the Director General
direzionegenerale@aifa.gov.it
Press & Communication Office
ufficiostampaaifa@aifa.gov.it
Chairmanship
presidenza@aifa.gov.it
Contacts
Switchboard
+39 06 5978401
Press & Communication Office
+39 06 59784419
Cookie Bar
Footer
The agency
Home Page
FarmaciLine
User participation and satisfaction
Citizens' access
Modulistica
Open governance
Acts of notification
Legal notification
TrovaNormeFarmaco
Competition notices
Tenders and contracts
Contacts
Via del Tritone, 181 00187 Roma
Contacts
Certified e-mail (PEC) contacts
VAT number: 08703841000
Tax code: 97345810580
IPA AIFA code: aifa_rm
IPA UCB code: UFE1TR
FOLLOW US ON
Facebook
Linkedin
label.button.spotify
Bluesky
Youtube
Linkedin
FEED RSS
Feed Rss
COOKIES
Cookie management
Sezione Link Utili
Legal notice
Social Media Policy
Dichiarazione di accessibilità
Web accessibility
Website statistics
Privacy
Online services
go to beginning of content